Didehydrotryptophan derivatives and pharmaceutical use thereof

Details Didehydrotryptophan derivatives and pharmaceutical use thereof Didehydrotryptophan derivatives and pharmaceutical use thereof

1992-02-18

1993-06-08

Springer, David B.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

548495, C07D20970, C07D40112, A61K 31405, A61K 3144

Patent

active

052181235

ABSTRACT:
Novel didehydrotryptophan derivatives useful as agents in the reduction of gastric acid secretion and in the treatment of anxiety, psychoses, and the symptoms of cognitive decline are disclosed. Processes for making the compounds and novel intermediates useful in the processes as well as compositions containing the compounds and methods of using them are also disclosed.

REFERENCES:
patent: 4814463 (1989-03-01), Kim
patent: 4902708 (1990-02-01), Kim
Regulatory Peptides, 14:277-291 (1986), R. Schick et al., "Intracerebroventricular injections of cholecystokinin . . . ".
Neuropharmacology, 26(4):389-300 (1987), R. Hill et al., "Antinociceptive Action of Cholecystokinin Octapeptide . . . ".
Brain Research, 406:130-135 (1987), B. MacVicar et al., "Inhibition of Synaptic Transmission in the hippocampus . . . ".
Brain Research, 288:199-211 (1983), G. Roberts et al., "Peptides, The Limbic Lobe and Schizophrenia".
Neuroscience, 19(1):181-192 (1986), S. Totterdell et al., "Cholecycystokinin-immunoreactive Boutons in Synaptic . . . ".
Pharmacology, Biochemistry & Behavior, 30:309-137 (1988), F. Weiss et al., "Opposite Actions of CCK-8 . . . ".
Peptides, 4:749-753 (1983), L. Schneider et al., "CCK-8 Modulation of Mesolimbic Dopamine: . . . ".
Gastrointestinal Hormones, (1980), CH. 23, S. Konturek, 529-564, "Gastrointestinal Hormones and Gastric Secretion".
ibid., CH. 22, pp. 507-527, L. Johnson, "Effect of Gastrointestinal Hormones on Growth of Gastrointestinal . . . ".
ibid., CH. 30, pp. 729-739, F. Stadil, "Gastrinomas".
Cancer Research, 46:1612-1616 (1986), P. Singh, "Role of Gastrin and Gastrin Receptors on the Growth . . . ".
Gastroenterology, 95:1541-1548 (1988), J. Smith et al., "Effects of Gastrin, Proglumide, and Somatostatin . . ".
British Medical Bulletin, 38(3):253-258 (1982), G. Dockray, "The physiology of Cholecystokinin in Brain and Gut".
Gastrointestinal Hormones, CH. 7 (1980), pp. 169-221, V. Mutt, "Cholecystokinin: Isolation, Structure . . . ".
Life Sciences, 27:355-368 (1980), J. Morley, "The Neuroendrocrine Control of Appetite: The Role of . . . ".
CCK in the Nervous System, CH. 7, (1984), pp. 110-127, M. Sheehan et al., "Central Actions of Cholecystokinin . . . ".
Journal of Neurochemistry, 32:1339-1341 (1979), "Immunochemical evidence of cholecystokinin Octapeptides: Continuous Picomole Injections into the Cerebral . . ".
Journal of Neuroscience, 8(3):988-1000 (1988), H. Demeulemeester et al., "Heterogeneity of GABAergic . . . ".
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th ed., (1985), pp. 339-371, CH. 17, S. Harvey, "Hypnotics and Sedatives".
Ann. Rev. Pharmacol. Toxicol., 31:469-501 (1991), G. Woodruff, "Cholecystokinin Antagonists".

Affiliated with

Also associated with

Rating

Didehydrotryptophan derivatives and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Didehydrotryptophan derivatives and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Didehydrotryptophan derivatives and pharmaceutical use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1935228